Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Glas

Showing results (1-10 of 141) with videos related to

Pageof 15
Sort By:
Therapeutic Advances in Medical Oncology|January 4, 2020
Regorafenib in glioblastoma recurrence: how to deal with conflicting 'real-life' experiences?Martin Glas, Sied Kebir
Expert Review of Neurotherapeutics|October 23, 2012
Primary CNS lymphoma: a clinician's guideNiklas Schäfer, Martin Glas, Ulrich Herrlinger
The European Journal of Neuroscience|April 7, 2004
Mouse photoreceptor synaptic ribbons lose and regain material in response to illumination changesIsabella Spiwoks-Becker, Martin Glas, Irina Lasarzik, et al.
Neurological Research and Practice|May 25, 2021
Simultaneous paraneoplastic cerebellar degeneration, Lambert-Eaton syndrome and neuropathy associated with AGNA/anti-SOX1 and VGCC antibodiesJonas Feldheim, Cornelius Deuschl, Martin Glas, et al.
Oncology|October 9, 2008
Procarbazine and CCNU as initial treatment in gliomatosis cerebriMartin Glas, Katja Rasch, Dorothee Wiewrodt, et al.
International Journal of Oncology|August 19, 2011
Pharmacological targeting of the constitutively activated MEK/MAPK-dependent signaling pathway in glioma cells inhibits cell proliferation and migrationAlexander Glassmann, Karl Reichmann, Björn Scheffler, et al.
International Journal of Dermatology|February 22, 2021
Severe ulcerations in corticosteroid-induced striae distensae rubrae under anti-vascular endothelial growth factor treatment of anaplastic astrocytomaThilo Gambichler, Martin Glas, Maria Chatzipantazi, et al.
The Journal of Headache and Pain|May 10, 2022
Twelve-month safety, tolerability and susceptibility to adverse events of prophylactic migraine therapy with erenumab: a retrospective real-world studyHannah Schenk, Dagny Holle, Michael Nsaka, et al.
River Research and Applications|August 1, 2020
Rheoreaction impacts dispersal of fish larvae in restored riversMartin Glas, Michael Tritthart, Hubert Keckeis, et al.
The Journal of Headache and Pain|September 21, 2021
CGRP antibody therapy in patients with drug resistant migraine and chronic daily headache: a real-world experienceArmin Scheffler, Hannah Schenk, Sebastian Wurthmann, et al.
Pageof 15

Showing results (1-10 of 141) with videos related to

Sort By:
Pageof 15
Therapeutic Advances in Medical Oncology|January 4, 2020
Regorafenib in glioblastoma recurrence: how to deal with conflicting 'real-life' experiences?Martin Glas, Sied Kebir
Expert Review of Neurotherapeutics|October 23, 2012
Primary CNS lymphoma: a clinician's guideNiklas Schäfer, Martin Glas, Ulrich Herrlinger
The European Journal of Neuroscience|April 7, 2004
Mouse photoreceptor synaptic ribbons lose and regain material in response to illumination changesIsabella Spiwoks-Becker, Martin Glas, Irina Lasarzik, et al.
Neurological Research and Practice|May 25, 2021
Simultaneous paraneoplastic cerebellar degeneration, Lambert-Eaton syndrome and neuropathy associated with AGNA/anti-SOX1 and VGCC antibodiesJonas Feldheim, Cornelius Deuschl, Martin Glas, et al.
Oncology|October 9, 2008
Procarbazine and CCNU as initial treatment in gliomatosis cerebriMartin Glas, Katja Rasch, Dorothee Wiewrodt, et al.
International Journal of Oncology|August 19, 2011
Pharmacological targeting of the constitutively activated MEK/MAPK-dependent signaling pathway in glioma cells inhibits cell proliferation and migrationAlexander Glassmann, Karl Reichmann, Björn Scheffler, et al.
International Journal of Dermatology|February 22, 2021
Severe ulcerations in corticosteroid-induced striae distensae rubrae under anti-vascular endothelial growth factor treatment of anaplastic astrocytomaThilo Gambichler, Martin Glas, Maria Chatzipantazi, et al.
The Journal of Headache and Pain|May 10, 2022
Twelve-month safety, tolerability and susceptibility to adverse events of prophylactic migraine therapy with erenumab: a retrospective real-world studyHannah Schenk, Dagny Holle, Michael Nsaka, et al.
River Research and Applications|August 1, 2020
Rheoreaction impacts dispersal of fish larvae in restored riversMartin Glas, Michael Tritthart, Hubert Keckeis, et al.
The Journal of Headache and Pain|September 21, 2021
CGRP antibody therapy in patients with drug resistant migraine and chronic daily headache: a real-world experienceArmin Scheffler, Hannah Schenk, Sebastian Wurthmann, et al.
Pageof 15